Artelo Biosciences Inc. (Nasdaq: ARTL) is a clinical-stage biopharmaceutical company focused on developing therapeutics that modulate lipid signaling pathways. The company's pipeline includes drug candidates targeting pain, inflammation, anxiety, and cancer-related conditions. The company is utilizing clinical trials to validate their safety and efficacy, and utilizes an outsourced model for both R&D and manufacturing management. Tags: Publicly listed company Founded:
